GLSI
GLSI
NASDAQ · Biotechnology

Greenwich Lifesciences Inc

Biotech Stocks Healthcare Stocks
$15.70
-0.65 (-3.98%)
As of Nov 5, 2:51 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +116.9% upside
Low Target $25.54
Average Target $34.05
High Target $45.13
Current Price $15.70
Current
$15.70
Target
$34.05
$25.54 $34.05 avg $45.13
Scenario Analysis
Bear Case
$25.54
62.7%
Low target
Base Case
$34.05
+116.9%
Avg target
Bull Case
$45.13
+187.5%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$34.10
-54.0% from high
52-Week Low
$7.78
+101.8% from low
Target vs 52W High
$34.05
-0.1% vs high
Next Earnings Report
Nov 12, 2026
5d
until earnings
EPS Est: $-0.34
Earnings in 5 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -35.8%